ArticleJACC. CardioOncology2023

Effectiveness and Safety of Rivaroxaban and Low Molecular Weight Heparin in Cancer-Associated Venous Thromboembolism.

Craig I Coleman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.